132 related articles for article (PubMed ID: 20673726)
1. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
[TBL] [Abstract][Full Text] [Related]
2. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
3. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
Kong W; Wei J; Abidi P; Lin M; Inaba S; Li C; Wang Y; Wang Z; Si S; Pan H; Wang S; Wu J; Wang Y; Li Z; Liu J; Jiang JD
Nat Med; 2004 Dec; 10(12):1344-51. PubMed ID: 15531889
[TBL] [Abstract][Full Text] [Related]
4. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.
Li YH; Yang P; Kong WJ; Wang YX; Hu CQ; Zuo ZY; Wang YM; Gao H; Gao LM; Feng YC; Du NN; Liu Y; Song DQ; Jiang JD
J Med Chem; 2009 Jan; 52(2):492-501. PubMed ID: 19090767
[TBL] [Abstract][Full Text] [Related]
5. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ; Ren G; Wang YX; Pang J; Zhao ZY; Yao J; You XF; Si SY; Song DQ; Kong WJ; Jiang JD
Metabolism; 2013 Mar; 62(3):446-56. PubMed ID: 23079743
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents.
Park KD; Lee JH; Kim SH; Kang TH; Moon JS; Kim SU
Bioorg Med Chem Lett; 2006 Aug; 16(15):3913-6. PubMed ID: 16730982
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, ADME properties, and pharmacological activities of β-alanyl-D-histidine (D-carnosine) prodrugs with improved bioavailability.
Orioli M; Vistoli G; Regazzoni L; Pedretti A; Lapolla A; Rossoni G; Canevotti R; Gamberoni L; Previtali M; Carini M; Aldini G
ChemMedChem; 2011 Jul; 6(7):1269-82. PubMed ID: 21634010
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
Xie Q; Wang X; Wang X; Jiang Z; Qiu Z
Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering effect of berberine in human subjects and rats.
Hu Y; Ehli EA; Kittelsrud J; Ronan PJ; Munger K; Downey T; Bohlen K; Callahan L; Munson V; Jahnke M; Marshall LL; Nelson K; Huizenga P; Hansen R; Soundy TJ; Davies GE
Phytomedicine; 2012 Jul; 19(10):861-7. PubMed ID: 22739410
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a series of liver-selective phosphonic acid thyroid hormone receptor agonists and their prodrugs.
Boyer SH; Jiang H; Jacintho JD; Reddy MV; Li H; Li W; Godwin JL; Schulz WG; Cable EE; Hou J; Wu R; Fujitaki JM; Hecker SJ; Erion MD
J Med Chem; 2008 Nov; 51(22):7075-93. PubMed ID: 18975928
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine.
Yang N; Sun RB; Chen XL; Zhen L; Ge C; Zhao YQ; He J; Geng JL; Guo JH; Yu XY; Fei F; Feng SQ; Zhu XX; Wang HB; Fu FH; Aa JY; Wang GJ
Acta Pharmacol Sin; 2017 Mar; 38(3):351-361. PubMed ID: 28042874
[TBL] [Abstract][Full Text] [Related]
12. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
13. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
14. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
Wang YX; Wang YP; Zhang H; Kong WJ; Li YH; Liu F; Gao RM; Liu T; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2009 Nov; 19(21):6004-8. PubMed ID: 19800225
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
Yang JZ; Chen W; Borchardt RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators.
Yang P; Song DQ; Li YH; Kong WJ; Wang YX; Gao LM; Liu SY; Cao RQ; Jiang JD
Bioorg Med Chem Lett; 2008 Aug; 18(16):4675-7. PubMed ID: 18644725
[TBL] [Abstract][Full Text] [Related]
18. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
19. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.
Cheng Z; Chen AF; Wu F; Sheng L; Zhang HK; Gu M; Li YY; Zhang LN; Hu LH; Li JY; Li J
Bioorg Med Chem; 2010 Aug; 18(16):5915-24. PubMed ID: 20663675
[TBL] [Abstract][Full Text] [Related]
20. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats.
Xu G; Huang X; Qiu L; Wu J; Hu Y
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():313-7. PubMed ID: 17392126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
